Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages

Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages
复制标题

DOI:
10.4049/jimmunol.169.11.6408
复制
发表时间:
2002-12-01
影响因子:
4.4
通讯作者:
Liu, YS
Liu, YS
中科院分区:
医学2区
文献类型:
--
作者:
Chen, PL;Li, J;Liu, YS

文献摘要

被引文献

相似文献

巨噬细胞暴露于LPS会通过复杂的信号传导机制产生促炎细胞因子,如tnf - α。丝裂原活化蛋白(MAP)激酶在这一过程中起着关键作用。在本研究中,我们利用RAW264.7巨噬细胞研究了MAP激酶磷酸酶-1 (MKP-1)在调节促炎细胞因子产生中的作用。MAP激酶活性分析显示,LPS刺激后c-Jun n -末端激酶(JNK)和p38瞬间活化。有趣的是,MKP-1在JNK和p38失活的同时被诱导,而雷公藤甲素阻断MKP-1的诱导可以阻止这种失活。MKP-1的异位表达加速了JNK和p38的失活,并显著抑制了tnf - α和IL-6的产生。发现LPS诱导MKP-1依赖于细胞外信号调节的激酶,并涉及基因表达增强和蛋白质稳定性增加。最后,在动物模型中,糖皮质激素和霍乱毒素B亚基(一种能够预防自身免疫性疾病的药物)也能诱导MKP-1表达。这些发现强调了MKP-1作为巨噬细胞炎症反应的关键负调节因子,强调了其作为开发新型抗炎药物的潜在靶点的前提。
Exposure of macrophages to LPS elicits the production of proinflammatory cytokines, such as TNF-alpha, through complex signaling mechanisms. Mitogen-activated protein (MAP) kinases play a critical role in this process. In the present study, we have addressed the role of MAP kinase phosphatase-1 (MKP-1) in regulating proinflammatory cytokine production using RAW264.7 macrophages. Analysis of MAP kinase activity revealed a transient activation of c-Jun N-terminal kinase (JNK) and p38 after LPS stimulation. Interestingly, MKP-1 was induced concurrently with the inactivation of JNK and p38, whereas blocking MKP-1 induction by triptolide prevented this inactivation. Ectopic expression of MKP-1 accelerated JNK and p38 inactivation and substantially inhibited the production of TNF-alpha and IL-6. Induction of MKP-1 by LPS was found to be extracellular signal-regulated kinase dependent and involved enhanced gene expression and increased protein stability. Finally, MKP-1 expression was also induced by glucocorticoids as well as cholera toxin B subunit, an agent capable of preventing autoimmune diseases in animal models. These findings highlight MKP-1 as a critical negative regulator of the macrophage inflammatory response, underscoring its premise as a potential target for developing novel anti-inflammatory drugs.